NO941462L - Metoder og sammensetninger for profylaktisk og/eller terapeutisk behandling av organhypofunksjon - Google Patents

Metoder og sammensetninger for profylaktisk og/eller terapeutisk behandling av organhypofunksjon

Info

Publication number
NO941462L
NO941462L NO941462A NO941462A NO941462L NO 941462 L NO941462 L NO 941462L NO 941462 A NO941462 A NO 941462A NO 941462 A NO941462 A NO 941462A NO 941462 L NO941462 L NO 941462L
Authority
NO
Norway
Prior art keywords
prophylactic
compositions
methods
therapeutic treatment
hypofunction
Prior art date
Application number
NO941462A
Other languages
English (en)
Other versions
NO941462D0 (no
Inventor
Toshifumi Watanabe
Mitsuhiro Wakimasu
Chieko Kitada
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO941462D0 publication Critical patent/NO941462D0/no
Publication of NO941462L publication Critical patent/NO941462L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forbindelser med antagonistisk aktivitet på endotelin- reseptorer kan effektivt bli benyttet for profylakse og/eller behandling av hypofunksjon av organer som skjer ved kirurgi eller transplantering av organer.
NO941462A 1993-04-21 1994-04-21 Metoder og sammensetninger for profylaktisk og/eller terapeutisk behandling av organhypofunksjon NO941462L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9433293 1993-04-21

Publications (2)

Publication Number Publication Date
NO941462D0 NO941462D0 (no) 1994-04-21
NO941462L true NO941462L (no) 1994-10-24

Family

ID=14107334

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941462A NO941462L (no) 1993-04-21 1994-04-21 Metoder og sammensetninger for profylaktisk og/eller terapeutisk behandling av organhypofunksjon

Country Status (5)

Country Link
US (1) US6147051A (no)
EP (1) EP0626174A3 (no)
CA (1) CA2121724A1 (no)
FI (1) FI941826A (no)
NO (1) NO941462L (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
GB9504854D0 (en) * 1994-03-31 1995-04-26 Zeneca Ltd Nitrogen derivatives
US5612359A (en) * 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5760038A (en) * 1995-02-06 1998-06-02 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
US5780473A (en) * 1995-02-06 1998-07-14 Bristol-Myers Squibb Company Substituted biphenyl sulfonamide endothelin antagonists
UA58494C2 (uk) * 1995-06-07 2003-08-15 Зенека Лімітед Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
GB9512697D0 (en) * 1995-06-22 1995-08-23 Zeneca Ltd Heterocyclic compounds
US5846990A (en) * 1995-07-24 1998-12-08 Bristol-Myers Squibb Co. Substituted biphenyl isoxazole sulfonamides
JPH09124620A (ja) 1995-10-11 1997-05-13 Bristol Myers Squibb Co 置換ビフェニルスルホンアミドエンドセリン拮抗剤
US5977117A (en) 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5856507A (en) * 1997-01-21 1999-01-05 Bristol-Myers Squibb Co. Methods for the preparation of biphenyl isoxazole sulfonamides
BR9708151A (pt) 1996-02-20 1999-07-27 Bristol Myers Squibb Co Processo para a preparaç o de bifenil isoxazol sulfonamidas
US5939446A (en) * 1996-04-09 1999-08-17 Bristol-Myers Squibb Co. Heteroaryl substituted phenyl isoxazole sulfonamide endothelin antagonists
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
EP0815870A3 (en) 1996-06-27 2000-05-03 Takeda Chemical Industries, Ltd. Composition for prohylaxis or treatment of cerebral infarction
TW536540B (en) * 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
AU6187898A (en) * 1997-01-30 1998-08-25 Bristol-Myers Squibb Company Method for preventing or treating low renin hypertension by administering an endothelin antagonist
SG100767A1 (en) 1997-04-28 2003-12-26 Texas Biotechnology Corp Sulfonamides for treatment of endothelin-mediated disorders
US5783705A (en) 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
DE19743681A1 (de) * 1997-10-02 1999-04-08 Knoll Ag Methode zur Verhinderung der Transplantatabstoßung
MXPA01009362A (es) 1999-03-19 2002-06-04 Squibb Bristol Myers Co Metodos para la preparacion de bifenil isoxazol sulfonamidas.
WO2003006041A1 (fr) * 2001-07-12 2003-01-23 Takeda Chemical Industries, Ltd. Agents prophylactiques/therapeutiques contre les tumeurs malignes
US6562848B1 (en) 2001-09-18 2003-05-13 Bristol-Myers Squibb Company Bis-amino acid sulfonamides as HIV protease inhibitors
SI1664050T1 (sl) * 2003-09-03 2016-04-29 Neuren Pharmaceuticals Limited Nevroprotektične biciklične spojine in farmacevtski sestavki, vsebujoči le-te
GB201810581D0 (en) 2018-06-28 2018-08-15 Ctxt Pty Ltd Compounds
PL3986890T3 (pl) 2019-06-18 2024-03-11 Pfizer Inc. Pochodne benzizoksazolosulfonamidu

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650750T2 (de) 1985-07-08 2001-07-12 Energy Conversion Devices Inc Datenspeichervorrichtung
JP3061631B2 (ja) * 1989-10-11 2000-07-10 山之内製薬株式会社 新規なヘテロ環化合物およびその製造法
CA2032559C (en) 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
US5306808A (en) 1990-02-26 1994-04-26 Takeda Chemical Industries, Ltd. Peptide derivatives having vasodilating activity
JPH05503105A (ja) 1990-02-26 1993-05-27 武田薬品工業株式会社 ペプチド誘導体およびその製造法
US5214130A (en) * 1990-02-27 1993-05-25 Merck & Co., Inc. Synthesis of novel immunosuppressive cyclosporin analogs with modified amino acids at position-8
US5284828A (en) 1990-05-14 1994-02-08 Fujisawa Pharmaceutical Co. Ltd. Peptide compound and its preparation
JPH0427785A (ja) 1990-05-23 1992-01-30 Kayaba Ind Co Ltd ２連型ベーンポンプ
CA2043741C (en) 1990-06-07 2003-04-01 Kiyofumi Ishikawa Endothelin antagonistic peptide derivatives
GB9100721D0 (en) 1991-01-12 1991-02-27 Japat Ltd Endothelin antagonists
CA2059380A1 (en) 1991-01-24 1992-07-25 Yiu-Kuen T. Lam Endothelin receptor antagonists isolated from microbispora
DK0526642T3 (da) * 1991-01-29 1998-10-19 Shionogi & Co Triterpenderivat
EP0499266B1 (en) 1991-02-15 1996-07-10 Takeda Chemical Industries, Ltd. Endothelin antagonist
TW270116B (no) 1991-04-25 1996-02-11 Hoffmann La Roche
ATE195948T1 (de) 1991-05-16 2000-09-15 Warner Lambert Co Endothelinantagonisten
RU2086544C1 (ru) 1991-06-13 1997-08-10 Хоффманн-Ля Рош АГ Бензолсульфонамидные производные пиримидина или их соли, фармацевтическая композиция для лечения заболеваний, связанных с активностью эндотелина
ATE155486T1 (de) 1991-08-13 1997-08-15 Takeda Chemical Industries Ltd Zyklische peptide und ihre verwendung
DK0612244T3 (da) 1991-11-05 2002-01-14 Smithkline Beecham Corp Endothelinreceptorantagonister
TW217417B (no) 1991-12-04 1993-12-11 Manyu Seiyaku Kk
JPH05178890A (ja) 1991-12-26 1993-07-20 Banyu Pharmaceut Co Ltd エンドセリン拮抗性化合物
JPH06172384A (ja) 1991-12-27 1994-06-21 Takeda Chem Ind Ltd ペプチド、その製造法および用途
US5614497A (en) 1991-12-27 1997-03-25 Takeda Chemical Industries, Ltd. Peptide, production and use thereof
EP0603399B1 (en) * 1991-12-27 2002-09-11 Kyowa Hakko Kogyo Kabushiki Kaisha Endothelin-antagonizing peptide
JPH05279390A (ja) 1992-02-06 1993-10-26 Banyu Pharmaceut Co Ltd エンドセリン拮抗性環状ペンタペプチド
TW224462B (no) 1992-02-24 1994-06-01 Squibb & Sons Inc
WO1993017701A1 (en) 1992-03-12 1993-09-16 The Administrators Of The Tulane Educational Fund Endothelin receptor-binding peptides
US5240910A (en) * 1992-04-17 1993-08-31 Merck & Co., Inc. Antihypertensive compounds produced by fermentation
AU678357B2 (en) 1992-04-22 1997-05-29 Warner-Lambert Company Endothelin antagonists II
NZ247440A (en) 1992-05-06 1995-04-27 Squibb & Sons Inc Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof
US5514696A (en) * 1992-05-06 1996-05-07 Bristol-Myers Squibb Co. Phenyl sulfonamide endothelin antagonists
WO1993023404A1 (en) 1992-05-19 1993-11-25 Immunopharmaceutics, Inc. Compounds that modulate endothelin activity
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
TW299333B (no) * 1992-12-29 1997-03-01 Takeda Pharm Industry Co Ltd

Also Published As

Publication number Publication date
EP0626174A3 (en) 1996-01-03
FI941826A (fi) 1994-10-22
CA2121724A1 (en) 1994-10-22
EP0626174A2 (en) 1994-11-30
NO941462D0 (no) 1994-04-21
US6147051A (en) 2000-11-14
FI941826A0 (fi) 1994-04-20

Similar Documents

Publication Publication Date Title
NO941462L (no) Metoder og sammensetninger for profylaktisk og/eller terapeutisk behandling av organhypofunksjon
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK0480950T3 (da) Kombinationsterapi til profylakse for og/eller behandling af godartet prostatahypertrofi
DK0755249T3 (da) Anvendelse af Maillard-reaktionsinhibitor til behandling af amyloidose-baseret sygdom
NO2014010I1 (no) Radium 223 salt slik som Radium 223 diklorid
HK56897A (en) Benzocyclobutyl-or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases
DK1237549T3 (da) Lipoxin A4 og dets analoger til behandling af törre öjne
HUP0303917A2 (hu) Szterin abszorpció inhibitor(ok) kombinációi vérmódosítókkal és ezek alkalmazása vaszkuláris kondíciók kezelésére
PT705100E (pt) Guanidinas substituidas terapeuticas
NO20041598L (no) Fremgangsmater for behandling eller profylakse av vaskulaer betennelse ved anvendelse av sterolabsorpsjonsinhibitor(er)
UA41355C2 (uk) Засіб для лікування нейро-сніду
WO1993013207A3 (en) Novel human transglutaminases
EP1162956B8 (en) Compositions and methods for improving integrity of compromised body passageways and cavities
DE60001555T2 (de) Wässrige lösung zum konservieren von gewebe und organen
NO982721D0 (no) Preserverende oppl°sning
DK0549666T3 (da) Nye aminobenzosultamderivater og deres anvendelse som lipoxygenaseinhibitorer
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
ES2088128T3 (es) Aminosulfonilureas inhibidoras de acat.
WO2004091436A3 (en) Methods and compositions for treating ocular disease
NO984760L (no) Anvendelse av en osmolytt ved behandling av effekter forÕrsaket av en infeksjon, en inflammasjon eller en immundysfunksjon
IS4763A (is) Samsetning til varðveislu á frystum líffærum og til meðhöndlunar á veiru og bakteríu sýkingum
GB9930768D0 (en) Composition
MX9705916A (es) Terapia de combinacion para infeccion por vih usando el inhibidor de proteasa de vih indinavir y el inhibidor de transcriptasa inversa 3tc, opcionalmente junto con azt, ddi, o ddc.
NO20012777D0 (no) Anvendelse av riluzol ved behandling av akustiske traumer
AU5625194A (en) Rectal flunisolide compositions for treating inflammatory intestinal disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application